| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication.
|
Am J Psychiatry
|
2006
|
11.85
|
|
2
|
The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study.
|
J Am Acad Child Adolesc Psychiatry
|
2009
|
6.71
|
|
3
|
Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.
|
J Am Acad Child Adolesc Psychiatry
|
2002
|
4.57
|
|
4
|
3-year follow-up of the NIMH MTA study.
|
J Am Acad Child Adolesc Psychiatry
|
2007
|
3.33
|
|
5
|
Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication.
|
Biol Psychiatry
|
2005
|
2.87
|
|
6
|
A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
|
Pediatrics
|
2004
|
2.32
|
|
7
|
Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.
|
J Am Acad Child Adolesc Psychiatry
|
2013
|
2.30
|
|
8
|
The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial.
|
J Am Acad Child Adolesc Psychiatry
|
2009
|
2.13
|
|
9
|
Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment.
|
J Am Acad Child Adolesc Psychiatry
|
2009
|
2.13
|
|
10
|
Morphological abnormalities of the thalamus in youths with attention deficit hyperactivity disorder.
|
Am J Psychiatry
|
2010
|
2.13
|
|
11
|
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up.
|
J Am Acad Child Adolesc Psychiatry
|
2007
|
2.03
|
|
12
|
Which treatment for whom for ADHD? Moderators of treatment response in the MTA.
|
J Consult Clin Psychol
|
2003
|
2.02
|
|
13
|
Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects.
|
J Am Acad Child Adolesc Psychiatry
|
2007
|
1.98
|
|
14
|
Frontostriatal connectivity and its role in cognitive control in parent-child dyads with ADHD.
|
Am J Psychiatry
|
2007
|
1.96
|
|
15
|
Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale.
|
Arch Gen Psychiatry
|
2010
|
1.68
|
|
16
|
Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses.
|
J Am Acad Child Adolesc Psychiatry
|
2007
|
1.48
|
|
17
|
Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD.
|
J Consult Clin Psychol
|
2003
|
1.46
|
|
18
|
Observed classroom behavior of children with ADHD: relationship to gender and comorbidity.
|
J Abnorm Child Psychol
|
2002
|
1.45
|
|
19
|
Psychopharmacological treatment for very young children: contexts and guidelines.
|
J Am Acad Child Adolesc Psychiatry
|
2007
|
1.44
|
|
20
|
Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study.
|
J Am Acad Child Adolesc Psychiatry
|
2009
|
1.44
|
|
21
|
Making research data available: an ethical imperative demonstrated by the SSRI debacle.
|
J Am Acad Child Adolesc Psychiatry
|
2004
|
1.43
|
|
22
|
Self-perceptions of competence in children with ADHD and comparison children.
|
J Consult Clin Psychol
|
2004
|
1.43
|
|
23
|
Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder.
|
J Clin Child Adolesc Psychol
|
2005
|
1.41
|
|
24
|
ADHD- and medication-related brain activation effects in concordantly affected parent-child dyads with ADHD.
|
J Child Psychol Psychiatry
|
2007
|
1.40
|
|
25
|
International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions.
|
Eur Neuropsychopharmacol
|
2004
|
1.38
|
|
26
|
Assessing medication effects in the MTA study using neuropsychological outcomes.
|
J Child Psychol Psychiatry
|
2006
|
1.34
|
|
27
|
Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder.
|
J Am Acad Child Adolesc Psychiatry
|
2006
|
1.30
|
|
28
|
Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.
|
J Am Acad Child Adolesc Psychiatry
|
2003
|
1.29
|
|
29
|
Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
|
J Child Adolesc Psychopharmacol
|
2007
|
1.24
|
|
30
|
Socioeconomic status as a moderator of ADHD treatment outcomes.
|
J Am Acad Child Adolesc Psychiatry
|
2002
|
1.23
|
|
31
|
Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.
|
Am J Psychiatry
|
2012
|
1.18
|
|
32
|
Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial.
|
J Child Adolesc Psychopharmacol
|
2003
|
1.15
|
|
33
|
How can we improve the assessment of safety in child and adolescent psychopharmacology?
|
J Am Acad Child Adolesc Psychiatry
|
2003
|
1.12
|
|
34
|
Assessment and prevention of head motion during imaging of patients with attention deficit hyperactivity disorder.
|
Psychiatry Res
|
2007
|
1.11
|
|
35
|
Basal ganglia surface morphology and the effects of stimulant medications in youth with attention deficit hyperactivity disorder.
|
Am J Psychiatry
|
2010
|
1.08
|
|
36
|
Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.
|
J Am Acad Child Adolesc Psychiatry
|
2003
|
1.06
|
|
37
|
Off-label psychopharmacologic prescribing for children: history supports close clinical monitoring.
|
Child Adolesc Psychiatry Ment Health
|
2008
|
1.06
|
|
38
|
Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures.
|
J Abnorm Child Psychol
|
2004
|
1.03
|
|
39
|
Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation.
|
J Clin Psychiatry
|
2006
|
1.02
|
|
40
|
Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
|
J Child Adolesc Psychopharmacol
|
2007
|
1.02
|
|
41
|
Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
|
J Child Adolesc Psychopharmacol
|
2007
|
1.01
|
|
42
|
Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder.
|
J Child Adolesc Psychopharmacol
|
2007
|
1.01
|
|
43
|
Trends in office-based treatment of adults with stimulants in the United States.
|
J Clin Psychiatry
|
2013
|
0.97
|
|
44
|
A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.
|
Pediatrics
|
2011
|
0.97
|
|
45
|
Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder.
|
J Consult Clin Psychol
|
2006
|
0.96
|
|
46
|
Acute atomoxetine treatment of younger and older children with ADHD: a meta-analysis of tolerability and efficacy.
|
Child Adolesc Psychiatry Ment Health
|
2008
|
0.93
|
|
47
|
A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder.
|
J Child Adolesc Psychopharmacol
|
2007
|
0.91
|
|
48
|
Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
|
J Child Adolesc Psychopharmacol
|
2007
|
0.90
|
|
49
|
Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
|
J Child Adolesc Psychopharmacol
|
2007
|
0.89
|
|
50
|
The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration.
|
Biol Psychiatry
|
2004
|
0.86
|
|
51
|
Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.
|
Cancer Lett
|
2005
|
0.85
|
|
52
|
Pharmacotherapy of child and adolescent depression.
|
Child Adolesc Psychiatr Clin N Am
|
2006
|
0.85
|
|
53
|
Neuroanatomical abnormalities in adolescents with attention-deficit/hyperactivity disorder.
|
J Am Acad Child Adolesc Psychiatry
|
2008
|
0.84
|
|
54
|
The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder.
|
CNS Drugs
|
2004
|
0.84
|
|
55
|
Developmental progression to early adult binge drinking and marijuana use from worsening versus stable trajectories of adolescent attention deficit/hyperactivity disorder and delinquency.
|
Addiction
|
2015
|
0.83
|
|
56
|
Blindness of clinical evaluators, parents, and children in a placebo-controlled trial of fluvoxamine.
|
J Child Adolesc Psychopharmacol
|
2006
|
0.83
|
|
57
|
A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.
|
J Child Adolesc Psychopharmacol
|
2014
|
0.80
|
|
58
|
Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies.
|
Prim Care Companion J Clin Psychiatry
|
2006
|
0.79
|
|
59
|
Atomoxetine tolerability in pediatric and adult patients receiving different dosing strategies.
|
J Clin Psychiatry
|
2013
|
0.79
|
|
60
|
Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
|
J Child Adolesc Psychopharmacol
|
2007
|
0.79
|
|
61
|
Child and parent predictors of perceptions of parent--child relationship quality.
|
J Atten Disord
|
2007
|
0.79
|
|
62
|
Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD.
|
Psychiatry Res
|
2010
|
0.77
|
|
63
|
Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution.
|
J Am Acad Child Adolesc Psychiatry
|
2002
|
0.77
|
|
64
|
Pharmacological management of preschool ADHD.
|
J Am Acad Child Adolesc Psychiatry
|
2006
|
0.76
|
|
65
|
Diagnosing and managing complicated ADHD.
|
Prim Care Companion J Clin Psychiatry
|
2008
|
0.75
|
|
66
|
Response to commentary on the multimodal treatment study of ADHD (MTA): mining the meaning of the MTA.
|
J Abnorm Child Psychol
|
2002
|
0.75
|
|
67
|
Cautious reassurance: cardiovascular risk in the context of stimulant use.
|
J Am Acad Child Adolesc Psychiatry
|
2012
|
0.75
|
|
68
|
Hats off: journal awards.
|
J Am Acad Child Adolesc Psychiatry
|
2008
|
0.75
|
|
69
|
Mental health and extracurricular education in Korean first graders: a school-based cross-sectional study.
|
J Clin Psychiatry
|
2011
|
0.75
|
|
70
|
Diagnosing and managing complicated ADHD.
|
J Clin Psychiatry
|
2007
|
0.75
|
|
71
|
Hats off: 2010 Journal awards.
|
J Am Acad Child Adolesc Psychiatry
|
2010
|
0.75
|